Annals of internal medicine
-
Randomized Controlled Trial Multicenter Study
Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.
Limited data compare once-daily options for initial therapy for HIV-1. ⋯ National Institutes of Health.